Skip to main content

and
  1. No Access

    Article

    Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer

    Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50% of patients are cisplatin ineligible. The aim of this ...

    Sarah M. H. Einerhand, Anna J. Black, Homayoun Zargar in World Journal of Urology (2022)

  2. Article

    Open Access

    Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer

    To assess the association of patient age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer (MIBC).

    David D’Andrea, Peter C. Black, Homayoun Zargar in World Journal of Urology (2021)

  3. No Access

    Article

    Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study

    Hospital cystectomy volume has been associated with in-hospital perioperative mortality in previous studies. In this study, we examine the relationship between hospital cystectomy volume and 90-day mortality i...

    Michael P. Porter, John L. Gore, Jonathan L. Wright in World Journal of Urology (2011)